{"id":"W4283389183","doi":"10.1097/01.hs9.0000850912.43010.d3","title":"PB2020: MAJESTEC-3: RANDOMIZED, PHASE 3 STUDY OF TECLISTAMAB PLUS DARATUMUMAB VERSUS DPD OR DVD IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Institute of Cancer Research","funders":"","keywords":"Lenalidomide; Daratumumab; Medicine; Internal medicine; Pomalidomide; Oncology; Multiple myeloma; Bortezomib; Dexamethasone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002824047,0.001601191,0.002148122,0.0004872465,0.0006452408,0.001450865,0.001182319,0.001793065,0.005396069],"category_scores_gemma":[0.001496334,0.0008472847,0.002095705,0.0005126108,0.00128707,0.001196128,0.0005504387,0.004727595,0.001163702],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001496447,"about_ca_system_score_gemma":0.00224304,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001740816,"about_ca_topic_score_gemma":0.005112058,"domain_scores_codex":[0.9993513,0.0003251482,0.00003604818,0.000113101,0.00006320303,0.0001110623],"domain_scores_gemma":[0.9990935,0.0001644378,0.0001895881,0.00005631472,0.00005961985,0.0004365042],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9446607,0.02249861,0.001583289,0.0005806942,0.001041205,0.0001004884,0.0001110959,0.0005458921,0.005103138,0.0001381663,0.001802917,0.02183384],"study_design_scores_gemma":[0.9019461,0.09365294,0.002227164,0.00002352519,0.0002947498,0.00007485785,0.00002209808,0.0004281704,0.0003575954,0.000141287,0.0008153665,0.00001621619],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9801698,0.004669053,0.0006923489,0.001278319,0.0005374404,0.008310024,0.001776995,0.000223157,0.002342852],"genre_scores_gemma":[0.9797236,0.002759992,0.002352122,0.00263331,0.0005466976,0.006700684,0.001927836,0.00005110179,0.003304674],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005396069,"threshold_uncertainty_score":0.01805162,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02841387785979811,"score_gpt":0.3096109675587421,"score_spread":0.281197089698944,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}